Is now at
Argyll Park, Dixon, California


A pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.

Randomized, controlled medical data from multi-center studies is important to our customers, to nationwide transfusion services and to local regulatory authorities, and we look forwards to the publication of the investigators’ findings. Despite testing and various other measures, infections of conventional platelet components persists, and concern has led to storage limits of four or five days in lots of regions. Collection and source logistics have a substantial impact on cost, and are particularly challenging over holiday intervals when donation rates decline. Moreover, Germany’s recent 1 day reduction of the traditional platelet storage limit, to four days, has resulted in wastage rates approaching 20 % in some centers. Certain countries have granted storage extensions for up to seven days when anti-bacterial measures, including pathogen inactivation, are used during platelet production.In cell tradition, Boc-lysinated-betulonic acid inhibited the development of human prostate cancers cells by nearly 96 %, the Weill Cornell group reviews. And, in the first-ever in vivo trial executed with the substance, the new medication inhibited the development of grafted human being prostate cell tumors in mice by up to 92 % – without apparent toxic effects. ‘At this time we aren’t clear precisely how Boc-lysinated-betulonic acid kills prostate cancer tumor cells, but it appears to induce apoptosis – programmed cell loss of life,’ says a senior writer of this study, Dr.